Oxytocin receptor polymorphisms have been associated with depression and anxiety [13-15], and oxytocinergic activity has been shown to be dysregulated in women with both unipolar and bipolar depression [16-18], and it has been suggested as a potential therapeutic target for mental disorders [19,20]. Here, OXTR is linked to depressive symptom measurement.